Announcer Intro:
You’re listening to NeuroFrontiers on ReachMD. On this episode, the President of the European Committee for Treatment and Research in Multiple Sclerosis, also known as ECTRIMS, Dr. Mar Tintoré, will be talking about the opening ceremony of ECTRIMS 40th anniversary. She also serves as the Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d’Hebron in Barcelona, Spain. Let’s hear from her now.
Dr. Tintoré:
During the opening ceremony, we will celebrate ECTRIMS 40th anniversary, so we will see a very nice video trying to summarize how these 40 years have really changed the life of our patients and how we have been able to see how much the prognosis has improved; that we are able to diagnose much earlier, and we are able to treat much earlier, and we are able to use high-efficacy treatments much earlier.
This is going to be the fourth year in which we have organized a small ECTRIMS for patients. We are going to summarize what is the most important things, directly the same final date to deliver all these important outcomes directly to our patients. This is going to be the Patient Community Day, and it’s going to be both onsite but also virtually—these patients can connect from everywhere. It’s going to be translated for many of them with a simultaneous translation. So we have a very special guest coming to our opening, and we are super excited about it, but I cannot tell more. But this is going to be really very exciting.
And of course, there’s still so much to be done and so much to be understood. But we have to celebrate this change in the quality of life of many of our patients that at least myself that have been in the field for the last 30 years this is pretty obvious that the prognosis is changing, and this is really something to celebrate, although there’s still so much to be done.
Announcer Outro:
That was Dr. Mar Tintoré telling us about the impact of ECTRIMS over 40 years on patients’ quality of life. To access this and other episodes in our series, visit NeuroFrontiers on ReachMD.com, where you can Be Part of the Knowledge. Thanks for listening!